Terremoto

Terremoto

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.terremotobio.com

Last Round

Series C

Apr 15, 2026

Total Funding Raised

$358M

Company Overview

Terremoto Biosciences is a biotechnology company that develops a drug delivery and discovery platform for small-molecule medicines, enabling the creation of therapies with enhanced clinical profiles and improved therapeutic benefits for serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

covalent medicineslysine targetingsmall molecule drug discoverydrug discovery platformundruggable targetscovalent inhibitorscovalent drug discoverymedicinal chemistryoncologypreclinical biotechbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terremoto Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Terremoto Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CApr 15, 2026
Series BNov 2, 2023
Series AMay 25, 2022

Key People

Founding team and executive leadership

Charles Baum

CEO And Board Member

Executive Team

Terremoto Investors

Notable investors and investment history

InvestorRounds
EcoR1 CapitalSeries B
RA Capital ManagementSeries C
Deep Track CapitalSeries C
Osage University PartnersSeries C
OrbiMedSeries C, Series B, Series A
Cormorant CapitalSeries B
Novo HoldingsSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    $108M round completed.

  • Jan 10, 2025

    James Christensen appointed President and Head of Research & Development.

Terremoto Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terremoto Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terremoto's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range57
Year Founded2021
Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.